119 related articles for article (PubMed ID: 38763496)
1. Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice.
Babalola JA; Stracke A; Loeffler T; Schilcher I; Sideromenos S; Flunkert S; Neddens J; Lignell A; Prokesch M; Pazenboeck U; Strobl H; Tadic J; Leitinger G; Lass A; Hutter-Paier B; Hoefler G
Mol Metab; 2024 Jul; 85():101959. PubMed ID: 38763496
[TBL] [Abstract][Full Text] [Related]
2. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
[TBL] [Abstract][Full Text] [Related]
3. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
[TBL] [Abstract][Full Text] [Related]
5. High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Bosoi CR; Vandal M; Tournissac M; Leclerc M; Fanet H; Mitchell PL; Verreault M; Trottier J; Virgili J; Tremblay C; Lippman HR; Bajaj JS; Barbier O; Marette A; Calon F
Hepatol Commun; 2021 Mar; 5(3):446-460. PubMed ID: 33681678
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
Fawver JN; Ghiwot Y; Koola C; Carrera W; Rodriguez-Rivera J; Hernandez C; Dineley KT; Kong Y; Li J; Jhamandas J; Perry G; Murray IV
Curr Alzheimer Res; 2014; 11(10):928-40. PubMed ID: 25387341
[TBL] [Abstract][Full Text] [Related]
7. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
10. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
[TBL] [Abstract][Full Text] [Related]
11. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
[TBL] [Abstract][Full Text] [Related]
12. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.
Fitz NF; Cronican A; Pham T; Fogg A; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2010 May; 30(20):6862-72. PubMed ID: 20484628
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
15. Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.
Babalola JA; Lang M; George M; Stracke A; Tam-Amersdorfer C; Itxaso I; Lucija D; Tadic J; Schilcher I; Loeffler T; Flunkert S; Prokesch M; Leitinger G; Lass A; Hutter-Paier B; Panzenboeck U; Hoefler G
Brain Res; 2023 Nov; 1819():148518. PubMed ID: 37579986
[TBL] [Abstract][Full Text] [Related]
16. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
17. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.
Moreno-Gonzalez I; Edwards Iii G; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C
Mol Psychiatry; 2017 Sep; 22(9):1327-1334. PubMed ID: 28044060
[TBL] [Abstract][Full Text] [Related]
18. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-fat diet on cognitive impairment in triple-transgenic mice model of Alzheimer's disease.
Sah SK; Lee C; Jang JH; Park GH
Biochem Biophys Res Commun; 2017 Nov; 493(1):731-736. PubMed ID: 28865961
[TBL] [Abstract][Full Text] [Related]
20. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner.
Gannon OJ; Robison LS; Salinero AE; Abi-Ghanem C; Mansour FM; Kelly RD; Tyagi A; Brawley RR; Ogg JD; Zuloaga KL
J Neuroinflammation; 2022 May; 19(1):110. PubMed ID: 35568928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
